Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Goodwill (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Goodwill over the past 15 years, most recently at $13.9 million for Q2 2025.

  • Quarterly results put Goodwill at $13.9 million for Q2 2025, changed 0.0% from a year ago — trailing twelve months through May 2025 was $13.9 million (changed 0.0% YoY), and the annual figure for FY2025 was $13.9 million, changed 0.0%.
  • Goodwill for Q2 2025 was $13.9 million at Lifecore Biomedical, Inc. \De\, roughly flat from $13.9 million in the prior quarter.
  • Over the last five years, Goodwill for LFCR hit a ceiling of $13.9 million in Q2 2022 and a floor of $13.9 million in Q1 2021.
  • Median Goodwill over the past 5 years was $13.9 million (2021), compared with a mean of $13.9 million.
  • Biggest five-year swings in Goodwill: plummeted 82.03% in 2021 and later increased 0.14% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Goodwill stood at $13.9 million in 2021, then changed by 0.0% to $13.9 million in 2022, then changed by 0.0% to $13.9 million in 2023, then changed by 0.0% to $13.9 million in 2024, then changed by 0.0% to $13.9 million in 2025.
  • The last three reported values for Goodwill were $13.9 million (Q2 2025), $13.9 million (Q1 2025), and $13.9 million (Q4 2024) per Business Quant data.